The weekly litigation news digest is live. Subscribe now

IP Verse

Method Of Treating Cancer Using Selective Estrogen Receptor Modulators - EP3122426

The patent EP3122426 was granted to Duke University on Jan 18, 2023. The application was filed on Mar 28, 2015 under application number EP15769394A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3122426

DUKE UNIVERSITY
Application Number
EP15769394A
Filing Date
Mar 28, 2015
Status
Granted And Under Opposition
Dec 16, 2022
Publication Date
Jan 18, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SANDOZOct 18, 2023ELKINGTON AND FIFEADMISSIBLE
TEVA PHARMACEUTICALSOct 4, 2023VON KAUFFMANNADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5681835
INTERNATIONAL-SEARCH-REPORTUS2006116364
OPPOSITIONUS2006116364
OPPOSITIONWO2008002490
OPPOSITIONWO2009137104
OPPOSITIONWO2015149045
SEARCHWO2009137104

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents